ConductScience.org, home

Paper39160255

Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes.

Skerget S and 58 others. Nat Genet, 2024. Cited by 90 papers, by iCite.

Cite this record

ConductScience Library. Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes. Papers, record 39160255. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39160255

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes.
PubMed
Journal
Nat Genet
PubMed
Year
2024
PubMed
Publication types
Journal Article, Observational Study
PubMed
Citations, by iCite
90
iCite
Relative citation ratio, by iCite
11.18, provisional
iCite
Revised in PubMed
2026-09-03
PubMed

Authors59

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Skerget SSheri
2Penaherrera DDaniel
3Chari AAjaihttps://orcid.org/0000-0002-0405-7480
4Jagannath SSundarhttps://orcid.org/0000-0003-2934-6518
5Siegel DSDavid Shttps://orcid.org/0000-0002-3604-2574
6Vij RRavi
7Orloff GGregory
8Jakubowiak AAndrzej
9Niesvizky RRuben
10Liles DDarlahttps://orcid.org/0000-0003-1480-7887
11Berdeja JJesushttps://orcid.org/0000-0003-4362-0376
12Levy MMoshe
13Wolf JJeffrey
14Usmani SZSaad Zhttps://orcid.org/0000-0002-5484-8731
15MMRF CoMMpass NetworkGroup
16Christofferson AWAustin W
17Nasser SSara
18Aldrich JLJessica L
19Legendre CChristophe
20Benard BBrookshttps://orcid.org/0000-0001-7154-744X

Source PubMed

See all 59 authorsDownload CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Multiple MyelomaMajor topic
DNA Copy Number VariationsMajor topic
Humans
Gene Expression Regulation, Neoplastic
Exome Sequencing
Gene Expression Profiling
Female
Male
Whole Genome Sequencing
Longitudinal Studies
Disease Progression
Middle Aged

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P30 CA008748NCI NIH HHSUnited StatesP30CA008748PubMed and NIHNIH RePORTER
CoMMpass StudyMultiple Myeloma Research Foundation (Multiple Myeloma Research Foundation, Inc.)PubMedPubMed

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Erratum in40490515Author Correction: Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes.https://conductscience.org/library/papers/40490515

Source PubMed

Download CSV of comments and corrections

References32

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16335483Non-random chromosomal aberrations associated with multiple myeloma.Hematol Oncol1984https://conductscience.org/library/papers/6335483PubMed
219687334Prognostic significance of copy-number alterations in multiple myeloma.J Clin Oncol2009https://conductscience.org/library/papers/19687334PubMed
316616336High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients.Cancer Cell2006https://conductscience.org/library/papers/16616336PubMed
46609674Translocation t(11;14) and trisomy 11q13----qter in multiple myeloma.Ann Genet1984https://conductscience.org/library/papers/6609674PubMed
58943038Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma.Proc Natl Acad Sci U S A1996https://conductscience.org/library/papers/8943038PubMed
611418483Cyclin D3 at 6p21 is dysregulated by recurrent chromosomal translocations to immunoglobulin loci in multiple myeloma.Blood2001https://conductscience.org/library/papers/11418483PubMed
711877296Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation.Blood2002https://conductscience.org/library/papers/11877296PubMed
815257707The recurrent translocation t(14;20)(q32;q12) in multiple myeloma results in aberrant expression of MAFB: a molecular and genetic analysis of the chromosomal breakpoint.Br J Haematol2004https://conductscience.org/library/papers/15257707PubMed
912805059The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma.Blood2003https://conductscience.org/library/papers/12805059PubMed
1024429703Heterogeneity of genomic evolution and mutational profiles in multiple myeloma.Nat Commun2014https://conductscience.org/library/papers/24429703PubMed
1124434212Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy.Cancer Cell2014https://conductscience.org/library/papers/24434212PubMed
1226282654Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma.J Clin Oncol2015https://conductscience.org/library/papers/26282654PubMed
1321430775Initial genome sequencing and analysis of multiple myeloma.Nature2011https://conductscience.org/library/papers/21430775PubMed
1415809451International staging system for multiple myeloma.J Clin Oncol2005https://conductscience.org/library/papers/15809451PubMed
1526240224Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group.J Clin Oncol2015https://conductscience.org/library/papers/26240224PubMed
1617692805Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma.Cancer Cell2007https://conductscience.org/library/papers/17692805PubMed
1716728703The molecular classification of multiple myeloma.Blood2006https://conductscience.org/library/papers/16728703PubMed
1820574050Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patients.Blood2010https://conductscience.org/library/papers/20574050PubMed
1925904160APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma.Nat Commun2015https://conductscience.org/library/papers/25904160PubMed
2031439946MYC dysregulation in the progression of multiple myeloma.Leukemia2020https://conductscience.org/library/papers/31439946PubMed

See all 32 referencesDownload CSV of references

Cited by76

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 90 citations.

PMIDTitleJournalYearIn PapersSource
42959892A proliferation score defined by PCLI-anchored transcriptomics predicts outcomes in multiple myeloma.Blood Neoplasia2026https://conductscience.org/library/papers/42959892PubMed
42912512APOBEC Status Classification Using a Curated Gene Panel in Multiple Myeloma.Hematol Oncol2026https://conductscience.org/library/papers/42912512PubMed
42902310Iron homeostasis landscape informs patient survival and neoadjuvant chemotherapy response in cancer.BioData Min2026https://conductscience.org/library/papers/42902310PubMed
42897348Molecular predictors of minimal residual disease in newly diagnosed multiple myeloma treated with quadruplet therapy.Nat Med2026https://conductscience.org/library/papers/42897348PubMed
42738384Dynamic Prediction of Survival Outcomes in Multiple Myeloma.Cancers (Basel)2026https://conductscience.org/library/papers/42738384PubMed
42704271Dynamic multimodal survival prediction in multiple myeloma integrating gene expression, longitudinal laboratory measurements, and treatment history.Brief Bioinform2026https://conductscience.org/library/papers/42704271PubMed
42702361Machine Learning-Derived Immune Gene Signature Predicts Prognosis and Therapeutic Vulnerabilities in Multiple Myeloma.Cancer Sci2026https://conductscience.org/library/papers/42702361PubMed
42697963KDM6A loss enhances oxidative phosphorylation uncovering tissue-level convergent evolution.EMBO J2026https://conductscience.org/library/papers/42697963PubMed
42680839A single-cell atlas of multiple myeloma defines malignant archetypes and proliferative states.Nat Genet2026https://conductscience.org/library/papers/42680839PubMed
42671911Phosphorylation Protects Oncogenic RAS from LZTR1-Mediated Degradation.Blood Cancer Discov2026https://conductscience.org/library/papers/42671911PubMed
42665737Real World Data and Its Impact on the Management of Plasma Cell Dyscrasias.Curr Hematol Malig Rep2026https://conductscience.org/library/papers/42665737PubMed
42602967TP53 mutation drives unique transcriptional and functional vulnerabilities independent of del(17p) in multiple myeloma.iScience2026https://conductscience.org/library/papers/42602967PubMed
42588711Skull-Base Plasmacytomas: A Systematic Review on Therapeutic Trends.Cancers (Basel)2026https://conductscience.org/library/papers/42588711PubMed
42511618Extracellular Vesicles as Master Regulators of Immune Modulation in Multiple Myeloma.Int J Mol Sci2026https://conductscience.org/library/papers/42511618PubMed
42490832Prognostic Significance of Isolated Beta 2-Microglobulin Elevation in Thai Multiple Myeloma: Impact of Renal Function Assessment.J Hematol2026https://conductscience.org/library/papers/42490832PubMed
42426380Global burden of multiple myeloma(1990-2021) and projections up to 2035: a methodical analysis leveraging the global burden of disease 2021 study and Mendelian randomization.J Egypt Natl Canc Inst2026https://conductscience.org/library/papers/42426380PubMed
42424601Schlafen 11 Is Overexpressed in Multiple Myeloma and Undergoes Nucleolar Translocation in Response to Bortezomib.Cancer Res Commun2026https://conductscience.org/library/papers/42424601PubMed
42393044Expression profile of CASSIOPEIA patients refines prognostic value of MRD negativity in multiple myeloma.Blood Cancer J2026https://conductscience.org/library/papers/42393044PubMed
42352940Inhibition of Fibroblast Growth Factor Receptor 3 Signaling by Ponatinib Reduces Growth and Cytokine Production of Multiple Myeloma Cells.Int J Mol Sci2026https://conductscience.org/library/papers/42352940PubMed
42284538Genomic Features Do Not Account for Differences in Multiple Myeloma Risk by Ancestry.Blood Cancer Discov2026https://conductscience.org/library/papers/42284538PubMed

See all 76 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39160255

GET https://conductscience.org/api/papers/v1/39160255/authors?page=2